Clinical Trials Directory

Trials / Completed

CompletedNCT02572154

Sperm DNA Fragmentation in Recurrent Pregnancy Loss

Male Factor in Early Recurrent Pregnancy Loss : Study of Sperm DNA Fragmentation in Patients With Unexplained Recurrent Pregnancy Loss.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

In human, 2% of couples experimented Recurrent pregnancy loss (RPL). Currently, while etiological investigations were performed, 40 to 50 % of RPL were unexplained. In animals' studies, several studies have underlined the importance of sperm quality for a normal embryo development. In human, epidemiological studies have demonstrated that several male risk factors have effects on development (male mediated development toxicology). However, few studies have explored sperm DNA fragmentation on embryo development but after in vitro fertilization. In natural pregnancy only rare studies have been performed but with different populations definitions and different methods of sperm exploration. In this context sperm DNA fragmentation exploration appears justified. The present study purpose to conduct a case - control study in order to research paternal role in RPL.

Conditions

Interventions

TypeNameDescription
OTHERBlood and sperm samples20 ml of blood and sperm samples for sperm DNA fragmentation exploration

Timeline

Start date
2012-09-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2015-10-08
Last updated
2025-12-15

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02572154. Inclusion in this directory is not an endorsement.